Literature DB >> 17130425

Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.

S S Houshmandi1, E I Surace, H B Zhang, G N Fuller, D H Gutmann.   

Abstract

Tumor suppressor in lung cancer-1 (TSLC1) loss is common in many human cancers, including meningioma. In this study, we demonstrate that TSLC1 protein and RNA expression is lost in 60% to 65% of high-grade gliomas, and that TSLC1 reintroduction into glioma cells results in growth suppression. Moreover, Tslc1 loss in mice results in increased astrocyte proliferation in vivo and in vitro. These data indicate that TSLC1 functions as a glioma tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130425     DOI: 10.1212/01.wnl.0000244472.56198.84

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  11q21.1-11q23.3 Is a site of intrinsic genomic instability triggered by irradiation.

Authors:  Nga Du; Pamela M Baker; To Uyen Do; Christine Bien; Carol M Bier-Laning; Sheetal Singh; Shyh-Jen Shih; Manual O Diaz; Andrew T Vaughan
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

2.  LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.

Authors:  Xiaoyong Qin; Jie Yao; Peiliang Geng; Xiangping Fu; Jinghui Xue; Zhiwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

3.  The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner.

Authors:  S Sean Houshmandi; Ryan J Emnett; Marco Giovannini; David H Gutmann
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

4.  Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.

Authors:  Dong Liu; Xianjun Feng; Xinjun Wu; Zhanguo Li; Wanling Wang; Yipeng Tao; Yonghua Xia
Journal:  Tumour Biol       Date:  2013-06-30

5.  Merlin is a potent inhibitor of glioma growth.

Authors:  Ying-Ka Ingar Lau; Lucas B Murray; Sean S Houshmandi; Yin Xu; David H Gutmann; Qin Yu
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

6.  Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.

Authors:  Baocai Lu; Wenyu Di; Huimin Wang; Huimin Ma; Jinsong Li; Qunmei Zhang
Journal:  Tumour Biol       Date:  2012-07-18

7.  The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Authors:  Marina Lafage-Pochitaloff; Bastien Gerby; Véronique Baccini; Laetitia Largeaud; Vincent Fregona; Naïs Prade; Pierre-Yves Juvin; Laura Jamrog; Pierre Bories; Sylvie Hébrard; Stéphanie Lagarde; Véronique Mansat-De Mas; Oliver M Dovey; Kosuke Yusa; George S Vassiliou; Joop H Jansen; Tobias Tekath; David Rombaut; Geneviève Ameye; Carole Barin; Audrey Bidet; John Boudjarane; Marie-Agnès Collonge-Rame; Carine Gervais; Antoine Ittel; Christine Lefebvre; Isabelle Luquet; Lucienne Michaux; Nathalie Nadal; Hélène A Poirel; Isabelle Radford-Weiss; Bénédicte Ribourtout; Steven Richebourg; Stéphanie Struski; Christine Terré; Isabelle Tigaud; Dominique Penther; Virginie Eclache; Michaela Fontenay; Cyril Broccardo; Eric Delabesse
Journal:  Blood Adv       Date:  2022-01-25

8.  A map of tumor-host interactions in glioma at single-cell resolution.

Authors:  Francesca Pia Caruso; Luciano Garofano; Fulvio D'Angelo; Kai Yu; Fuchou Tang; Jinzhou Yuan; Jing Zhang; Luigi Cerulo; Stefano M Pagnotta; Davide Bedognetti; Peter A Sims; Mario Suvà; Xiao-Dong Su; Anna Lasorella; Antonio Iavarone; Michele Ceccarelli
Journal:  Gigascience       Date:  2020-10-14       Impact factor: 6.524

9.  The function and clinical relevance of lncRNA UBE2CP3-001 in human gliomas.

Authors:  Zhengxiang Luo; Junchen Pan; Yi Ding; Yan-Song Zhang; Yanjun Zeng
Journal:  Arch Med Sci       Date:  2018-10-23       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.